Aehr Test Systems Full Year 2025 Earnings: US$0.13 loss per share (vs US$1.15 profit in FY 2024)
Aehr Test Systems (NASDAQ:AEHR) Full Year 2025 Results
Key Financial Results
- Revenue: US$59.0m (down 11% from FY 2024).
- Net loss: US$3.91m (down by 112% from US$33.2m profit in FY 2024).
- US$0.13 loss per share (down from US$1.15 profit in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Aehr Test Systems Earnings Insights
In the last 12 months, the only revenue segment was Designing, Manufacturing and Marketing of Advanced Test and Burn-In Products contributing US$59.0m. Notably, cost of sales worth US$35.0m amounted to 59% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$17.8m (63% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of US$403.0k. Explore how AEHR's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Semiconductor industry in the US.
Performance of the American Semiconductor industry.
The company's shares are down 6.6% from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Aehr Test Systems that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Aehr Test Systems might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.